My Cart (0 )
VeriPair™ NFAT/GATA Lentiviral Dual-Reporter System
Price range: $2,400.00 through $2,500.00
VeriPair™ NFAT/GATA Lentiviral Dual-Reporter System provides a branded VeriPair™ upgrade path from single TF reporter lentivirus to an integrated dual-reporter system with stronger normalization, cleaner assay logic, and premium modality options.
Have questions about this product? Our PhD-level staff is ready to assist. Email info@lipexogen.com
Available Options:
Specifications
VeriPair™ NFAT/GATA Lentiviral Dual-Reporter System
Overview
The VeriPair™ platform is LipExoGen’s integrated dual-reporter system for pathway analysis, combining a pathway-responsive experimental reporter with a constitutive internal control in the same construct. This design reduces variability from transduction efficiency, genomic integration, and cell number while supporting cleaner, more scalable assay workflows.
NFAT/GATA is measured using pathway-responsive NFAT/GATA elements driving the experimental reporter, alongside an EF1α-driven internal control cassette for normalization. This parent product groups the three VeriPair modalities: RedShift, Luciferase, and Fluorescence.
| VeriPair™ Dual-Reporter Lentivirus | |
| Blasticidin | |
| RedShift, Luciferase, Fluorescence | |
| -80°C | |
| Shipped on dry ice |
Product Data:
Advantages
- Single-construct dual-reporter design with built-in normalization.
- Premium RedShift tier enables one-step same-well luminescence on compatible instruments.
- Luciferase and fluorescence tiers provide flexible detection options across different labs and instruments.
- Direct pathway-specific analog to the corresponding TF Reporter Lentivirus source product.
Applications
- Pathway activity quantification with stronger normalization.
- Industry-friendly assay simplification and automation workflows.
- Stable line generation using the same integrated dual-reporter logic.